3624 results for «2064»

Filter By

3624 results

Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?

19 Nov 2023 – From PCR London Valves 2023

Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!

How does the role of the right heart and pulmonary vasculature influence patient selection?

TAVI durability and potential future solutions - LIVE case

19 Nov 2023 – From PCR London Valves 2023

In this session, you will learn more about the potential technical challenges associated with second-time TAVI procedures, and the importance of detailed CT imaging and careful pre-procedural planning. Discover the latest innovations and future direction of this key area of development.

  • Live case: An 83-year-old woman with type 2 diabetes, COPD...
TAVI durability and potential future solutions - LIVE case

Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 1) - what do I need to know to do the procedure safely?

19 Nov 2023 – From PCR London Valves 2023

Analyze in depth the case of a 64-year-old female patient with ischaemic cardiomyopathy with LVEF 40 % and severe ventricular mitral regurgitation, who previously had NSTE-ACS treated with LAD and circumflex PCI, and who presented with recent worsening heart failure and persistent NYHA class II-III, and...

Key questions in mitral TEER - what do I need to know to do the procedure safely?

How to treat my patient with secondary mitral regurgitation

20 Nov 2023 – From PCR London Valves 2023

How is secondary mitral regurgitation classified? How to choose between surgical and transcatheter intervention? How to determine the best transcatheter treatment option? Watch the debates sparked by the case studies presented in this PCR London Valves 2023 session to find out.

How to treat my patient with secondary mitral regurgitation

Abstracts session 1

06 Dec 2023 – From GulfPCR-GIM 2023

Broaden your knowledge with this selection of abstracts submitted to GulfPCR-GIM 2023, covering topics such as aortic procedures, LV function recovery after CTO recanalization, and the state of PCI in the region of Kurdistan in Iraq.

PCR London Valves 2023 Closing Ceremony

21 Nov 2023 – From PCR London Valves 2023

Experience the highlights of PCR London Valve 2023 in this video retrospective, followed by insights from the Course Directors as they reflect on 3 dynamic and fruitful days that united 3,700 participants. Gratitude is extended to all contributors whose support was instrumental in the event's success....

PCR London Valves 2023 Closing Ceremony

Challenging STEMI scenarios: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

Explore a selection of case studies focusing on challenging STEMI scenarios, such as an inferior STEMI with a large thrombus burden, management of coronary dissection in a patient with ectatic coronary artery, and an unusual case of an RCA with an anomalous origin. 

When complications storm through the cathlab: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

Advanced imaging strategies in transcatheter tricuspid valve therapies

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.

Advanced imaging strategies in transcatheter tricuspid valve therapies

Mastering techniques from basic to complex - TEER for degenerative mitral regurgitation and complex situations

16 Feb 2024 – From PCR Tokyo Valves 2024

In this teaching session, learn about common complex situations that may arise during TEER for mitral regurgitation. Explore how best to manage commissural mitral regurgitation and chordal entanglement, learn tips about imaging and implantation for degenerative mitral regurgitation, and more!

Mastering techniques from basic to complex - Complex scenarios

16 Feb 2024 – From PCR Tokyo Valves 2024

Learn how to deal with common complex scenarios that might occur during TAVI through this teaching session. Explore complex scenarios such as a balloon valve modification and fracture, valve embolisation, and coronary occlusion through these slides!

Facilitating coronary access after TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

What are the challenges in coronary access after TAVI and what techniques may be used to facilitate it? Join this session to learn the answers to that question, as well as gaining insight into how to optimize the coronary access in the index procedure.

The 2024 top Japanese abstracts

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding Japanese abstract submissions from PCR Tokyo Valves 2024, including a study on the effect of chronic kidney disease in clinical outcomes of Japanese patients treated with MitraClip system, and insight into the deformation of transcatheter heart valves with mitral valve-in-valve.

TAVI for bicuspid aortic stenosis patients - Recorded cases

05 Dec 2023 – From GulfPCR-GIM 2023

Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.

  • An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI for bicuspid aortic stenosis patients - LIVE case

Welcome to GulfPCR Valves 2023

05 Dec 2023 – From GulfPCR-GIM 2023

Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...

Welcome to GulfPCR Valves 2023

Essentials of lifetime management of TAVR patients using novel Myval THV

05 Dec 2023 – From GulfPCR-GIM 2023

Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...

Essentials of lifetime management of TAVR patients using novel Myval THV

Newer generation self-expanding platform: technical optimisation for common clinical challenges

05 Dec 2023 – From GulfPCR-GIM 2023

The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...

Newer generation self-expanding platform: technical optimisation for common clinical challenges

TAVI and access: alternating is wise

16 Jan 2024 – From GulfPCR-GIM 2023

Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...

TAVI and access: alternating is wise

Valve-in-valve: not as simple as it looks

05 Dec 2023 – From GulfPCR-GIM 2023

Thanks to this session, you will enhance your comprehension of anticipating, planning, and executing TAV-in-TAV procedures, and gain insights into preventing coronary obstruction during these interventions.

Valve-in-valve: not as simple as it looks

Evidence gap and new indications

05 Dec 2023 – From GulfPCR-GIM 2023

Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...

Evidence gap and new indications
Didn’t find what you were looking for?